Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2026-01-26 @ 9:01 PM
Study NCT ID:
NCT02159066
Status:
COMPLETED
Last Update Posted:
2024-03-05
First Post:
2014-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-28
First Submit QC Date:
None
Study First Post Date:
2014-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-12-27
Results First Submit QC Date:
None
Results First Post Date:
2024-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-06
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL